| Attenuating the atopic march: Meta-analysis of the dupilumab atopic dermatitis database for incident allergic events GP Geba, D Li, M Xu, K Mohammadi, R Attre, M Ardeleanu, B Musser Journal of Allergy and Clinical Immunology, 2022 | 35 | 2022 |
| Bisdemethoxycurcumin inhibits hepatocellular carcinoma proliferation through Akt inactivation via CYLD-mediated deubiquitination C Qiu, K Liu, S Zhang, S Gao, W Chen, D Li, Y Huang Drug Design, Development and Therapy 14, 993, 2020 | 21 | 2020 |
| Brief Alcohol Interventions are Effective through 6 Months: Findings from Marginalized Zero-inflated Poisson and Negative Binomial Models in a Two-step IPD Meta-analysis EY Mun, Z Zhou, D Huh, L Tan, D Li, EE Tanner-Smith, ST Walters, ... Prevention Science, 1-14, 2022 | 16 | 2022 |
| Oridonin sensitizes hepatocellular carcinoma to the anticancer effect of sorafenib by targeting the Akt pathway X Li, W Chen, K Liu, S Zhang, R Yang, K Liu, D Li, Y Huang Cancer Management and Research 12, 8081, 2020 | 10 | 2020 |
| Targeting macrophage M1 polarization suppression through PCAF inhibition alleviates autoimmune arthritis via synergistic NF-κB and H3K9Ac blockade J Li, F Ye, X Xu, P Xu, P Wang, G Zheng, G Ye, W Yu, Z Su, J Lin, Y Che, ... Journal of Nanobiotechnology 21 (1), 280, 2023 | 9 | 2023 |
| ALKBH5 facilitates CYP1B1 mRNA degradation via m6A demethylation to alleviate MSC senescence and osteoarthritis progression G Ye, J Li, W Yu, Z Xie, G Zheng, W Liu, S Wang, Q Cao, J Lin, Z Su, D Li, ... Experimental & Molecular Medicine, 1-14, 2023 | 8 | 2023 |
| Power analysis for cluster randomized trials with multiple binary co‐primary endpoints D Li, J Cao, S Zhang Biometrics 76 (4), 1064-1074, 2020 | 8 | 2020 |
| Sample size calculation for clinical trials with correlated count measurements based on the negative binomial distribution D Li, S Zhang, J Cao Statistics in Medicine 38 (28), 5413-5427, 2019 | 7 | 2019 |
| Decrotonylation of AKT1 promotes AKT1 phosphorylation and activation during myogenic differentiation Z Qian, J Ye, J Li, Y Che, W Yu, P Xu, J Lin, F Ye, X Xu, Z Su, D Li, Z Xie, ... Journal of Advanced Research, 2022 | 6 | 2022 |
| Sample size calculation for cluster randomized trials with zero‐inflated count outcomes Z Zhou, D Li, S Zhang Statistics in Medicine 41 (12), 2191-2204, 2022 | 4 | 2022 |
| Casirivimab+ imdevimab accelerates symptom resolution linked to improved COVID-19 outcomes across susceptible antibody and risk profiles D Li, M Xu, AT Hooper, D Rofail, KA Mohammadi, Y Chen, S Ali, T Norton, ... Scientific Reports 13 (1), 12784, 2023 | 3 | 2023 |
| A Machine-Learning Approach to Developing a Predictive Signature Based on Transcriptome Profiling of Ground-Glass Opacities for Accurate Classification and Exploring the Immune … Z Zhao, W Yin, X Peng, Q Cai, B He, S Shi, W Peng, G Tu, Y Li, D Li, ... Frontiers in Immunology 13, 2022 | 3 | 2022 |
| Incorporating pragmatic features into power analysis for cluster randomized trials with a count outcome D Li, S Zhang, J Cao Statistics in Medicine 39 (27), 4037-4050, 2020 | 2 | 2020 |
| A Simulation Study of the Performance of Statistical Models for Count Outcomes with Excessive Zeros: Focusing on the Marginalized Model Z Zhou, D Li, D Huh, M Xie, EY Mun arXiv preprint arXiv:2301.12674, 2023 | 1 | 2023 |
| Considering Over-Dispersion in the Sample Size Calculation for Clinical Trials With Repeated Count Measurements D Li, J Cao Statistics in Biopharmaceutical Research 11 (3), 283-291, 2019 | 1 | 2019 |
| Paired versus two-group experimental design for rheological studies of vocal fold tissues CC Xu, D Li, T Mau, E McPherson, M Du, S Zhang Journal of biomechanics 83, 150-156, 2019 | 1 | 2019 |
| Correction: Targeting macrophage M1 polarization suppression through PCAF inhibition alleviates autoimmune arthritis via synergistic NF-κB and H3K9Ac blockade J Li, F Ye, X Xu, P Xu, P Wang, G Zheng, G Ye, W Yu, Z Su, J Lin, Y Che, ... Journal of Nanobiotechnology 21 (1), 336-336, 2023 | | 2023 |
| BMAL1-TTK-H2Bub1 loop deficiency contributes to impaired BM-MSC-mediated bone formation in senile osteoporosis J Li, P Xu, W Yu, G Ye, F Ye, X Xu, Z Su, J Lin, Y Che, Z Zhang, Y Zeng, ... Molecular Therapy-Nucleic Acids, 2023 | | 2023 |
| Oridonin Sensitizes Hepatocellular Carcinoma to the Anticancer Effect of Sorafenib by Targeting the Akt Pathway [Corrigendum] X Li, W Chen, K Liu, S Zhang, R Yang, K Liu, D Li, Y Huang Cancer Management and Research 13, 2515-2516, 2021 | | 2021 |
